UPC Analytics
ENDE
Overview · Filed:

ORD_22245/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsCase Management OrdersMunich LDGeneric Order
  • 2025-07-17Procedural onlyproceduralGeneric Order

    The Munich Local Division issued a scheduling order following the interim conference in the Sanofi v. Accord/STADA/Reddy/Zentiva infringement actions, setting out next procedural steps pending the written reasoning from the EPO Board of Appeal decision on the relevant patent.